James C. Katzaroff - 12 May 2021 Form 4/A - Amendment Insider Report for GlobeStar Therapeutics Corp (GSTC)

Role
CEO, Director
Signature
James C. Katzaroff
Issuer symbol
GSTC
Transactions as of
12 May 2021
Net transactions value
+$50,000
Form type
4/A - Amendment
Filing time
04 Apr 2023, 11:24:30 UTC
Date Of Original Report
03 Apr 2023
Next filing
29 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GSTC Common stock Other $50,000 +7,042,253 +70% $0.007100 17,042,253 03 Apr 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GSTC Options Award $0 +30,000,000 $0.000000 30,000,000 12 May 2021 Common stock 30,000,000 $0.0300 Direct
transaction GSTC Options Award $0 +35,000,000 +117% $0.000000 65,000,000 24 Feb 2023 Common stock 35,000,000 $0.009000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired pursuant to conversion of debt of $50,000.
F2 Options vest 50% when granted and balance ratably on a daily basis during the 24 month period commencing on date of grant.
F3 Vested Options are exercisable 6 months after date of grant and thereafter until 5 years after the date of grant.

Remarks:

This Form 4/A Amendment No. 1 is being filed to correct a typographical error in Table I, box 4 on the original Form 4 filing. The shares acquired pursuant to conversion of debt of $50,000 has been corrected from 70,422,535 to 7,042,253.